SSRI discontinuation syndrome: Incidence and differences on three groups of patients treated with paroxetine;Sindrome da sospensione di SSRI: Incidenza e differenze su tre gruppi di pazienti in trattamento con paroxetina

Rivista di Psichiatria

Volumn 44, Issue 3, 2009, Pages 169-175

  Rusconi, Anna Carlotta ^a   Carlone, Cristiano ^a   Muscillo, Marco ^a   De'Fornari, Maria Antonietta Coccanari ^a   Podda, Livia ^a   Piccione, Michele ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Antidepressant therapy; Discontinuation syndrome; Paroxetine; SSRI

Indexed keywords

PAROXETINE;

ABDOMINAL PAIN; AGE; ANXIETY; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEPERSONALIZATION; DIZZINESS; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG WITHDRAWAL; GENDER; HEADACHE; HUMAN; INCIDENCE; MAJOR DEPRESSION; NIGHTMARE; PANIC; PATIENT COMPLIANCE; SEX DIFFERENCE; SYMPTOM; WITHDRAWAL SYNDROME;

ADULT; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PAROXETINE; SEROTONIN UPTAKE INHIBITORS; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 68349097311     PISSN: 00356484     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Iapichino S, Colzi A, Massimo V: Sindrome da sospensione: fattori patogenetici e differenziazione tra i diversi SSRI. Giornale Italiano di Psicopatologia, 2000, 6, n.1.
2. Wolfe RM: Antidepressant withdrawal reactions. American Family Physician, 1997, 56, 455-462.
3. Garner EM, Kelly MW, Thompson DF: Tricyclic antidepressant withdrawal syndrome. The Annals of Pharmacotherapy, 1993, 27, 1068-1072.
4. Bani A, Miniati M: Sindrome da sospensione da SSRI: un contribute clinico. Giornale Italiano di Psicopatologia, 2004, 10, n.2.
5. Medawar C: The antidepressant web. Marketing depression and making medicines work. International Journal Risk & Safety Medicine, 1997, 10, 75-126.
6. Schatzberg AF, Haddad P, Kaplan EM, Lejoyeux M, Rosenbaum JF, Young AH, et al.: Serotonin reuptake inhibitor discontinuation syndrome: a hypothetical definition. Journal of Clinical Psychiatry, 1997, 58 (suppl 7), 5-10.
7. Robinson DS: Antidepressant discontinuation syndrome. Primary Psychiatry, 2006, 13, 23-24.
8. Price JS, Waller PC, Wood SM, MacKay AV: A comparison of the post-marketing safety of four selective serotonin re-uptake inhibitors the investigation of symptoms occurring on withdrawal. British Journal of Clinical Pharmacology, 1996, 42, 757-763.
9. Barr LC, Goodman WK, Price LH: Physical symptoms associated with paroxetine discontinuation. American Journal of Psychiatry, 1994, 151, 289.
10. Lejoyeux M, Rodiere-Rein C, Ades J: Withdrawal syndrome from antidepressive drugs. Report of 5 cases [in French]. Encephale, 1992, 18, 251-255.
11. Haddad PM, Qureshi M: Misdiagnosis of antidepressant discontinuation symptoms. Acta Psychiatrica Scandinavica, 2000, 102, 466-467.
12. Rosenbaum JF, Zajecka J: Clinical management of antidepressant discontinuation. Journal of Clinical Psychiatry, 1997, 58 (suppl 7), 37-40.
13. Rosenbaum JF, Fava M, Hoog SL, Ascroft RC, Krebs WB: Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial. Biological Psychiatry, 1998, 44, 77-87.
14. Dilsaver SC, Greden FJ: Antidepressant withdrawal phenomena. Biological Psychiatry, 1984, 19, 237-256.
15. Coupland NJ, Bell CJ, Potokar JP: Serotonin reuptake inhibitor withdrawal. Journal of Clinical Psychopharmacology, 1996, 16, 356-362.
16. Bogetto F, Bellino S, Revello RB, Patria L: Discontinuation syndrome in dysthymic patients treated with selective serotonin reuptake inhibitors: a clinical investigation. CNS Drugs, 2002, 16, 273-283. (Pubitemid 34492934)
17. Haddad P: Newer antidepressants and the discontinuation syndrome. Journal of Clinical Psychiatry, 1997, 58 (suppl 7), 17-21.
18. Judge R, Parry MG, Quail D, Jacobson JG: Discontinuation symptoms: comparison of brief interruption in fluoxetine and paroxetine treatment. International Clinical Psychopharmacology, 2002, 17, 217-225.
19. Michelson D, Fava M, Amsterdam J, Apter J, Londborg P, Tamura R, et al.: Interruption of selective serotonin reuptake inhibitor treatment. Double-blind, placebo-controlled trial. British Journal of Psychiatry, 2000, 176, 362-368.
20. Black K, Shea C, Dursun S, Kutcher S: Selective serotonin reuptake inhibitor discontinuation syndrome: proposed diagnostic criteria. Journal Psychiatry of Neuroscience, 2000, 25, 255- 261. (Pubitemid 30641002)
21. Berber MJ: FINISH: remembering the discontinuation syndrome. Flu-like symptoms, insomnia, nausea, imbalance, sensory disturbances, and hyperarousal (anxiety/agitation). Journal of Clinical Psychiatry, 1998, 59, 255.
22. Haddad P, Lejoyeux M, Young A: Antidepressant discontinuation reactions are preventable and simple to treat. British Medical Journal, 1998, 316, 1105-1106.
23. Warner CH, Bobo W, Warner C, Reid S, Rachal J: Antidepressant discontinuation syndrome. American Family Physician, 2006, 74, 449-456.
24. Shelton RC: Steps following attainment of remission: discontinuation of antidepressant therapy. Primary Care Companion Journal of Clinical Psychiatry, 2001, 3, 172.
25. Zajecka J, Tracy KA, Mitchell S: Discontinuation symptoms after treatment with serotonin reuptake inhibitors: a literature review. Journal of Clinical Psychiatry, 1997, 58, 291-297. (Pubitemid 27362484)
26. Schatzberg AF, Haddad P, Kaplan EM, Lejoyeux M, Rosenbaum JF, Young AH, et al.: Possible biological mechanisms of the serotonin reuptake inhibitor discontinuation syndrome. Discontinuation Consensus Panel. Journal of Clinical Psychiatry, 1997, 58 (suppl 7), 23-27.
27. Gury C, Cousin F: Pharmacokinetics of SSRI antidepressants: half-life and clinical applicability. Encephale, 1999, 25, 470-476.
28. th ed. Montvale, NJ: Thomson PDR, 2005: 731, 1269, 1282, 1585, 1592, 1655, 1659, 1663, 1873, 1925-6, 2213, 2458, 2578, 2681, 3220, 3296, 3321, 3326,3430.
29. Shelton RC: Steps following attainment of remission: discontinuation of antidepressant therapy. Primary Care Companion Journal of Clinical Psychiatry, 2001, 3, 168-174.
30. Bull SA, Hu XH, Hunkeler EM, Lee JY, Ming EE, Markson LE, et al.: Discontinuation of use and switching of antidepressants: influence of patient-physician communication. JAMA, 2002, 288, 1403-1409.
31. Coupland NJ, Bell CJ, Potokar JP: Serotonin reuptake inhibitor withdrawal. Journal of Clinical Psychopharmacology, 1996, 16, 356-362.